• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

球孢子菌病严重程度的遗传及其他决定因素:临床医生视角

Genetic and Other Determinants for the Severity of Coccidioidomycosis: A Clinician's Perspective.

作者信息

Galgiani John N, Hsu Amy P, Powell Daniel A, Vyas Jatin M, Holland Steven M

机构信息

Valley Fever Center for Excellence, College of Medicine-Tucson, University of Arizona, Tucson, AZ 85721, USA.

Department of Medicine, College of Medicine-Tucson, University of Arizona, Tucson, AZ 85721, USA.

出版信息

J Fungi (Basel). 2023 May 11;9(5):554. doi: 10.3390/jof9050554.

DOI:10.3390/jof9050554
PMID:37233265
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10219288/
Abstract

The endemic fungal infection, coccidioidomycosis, occurs after inhalation of one or very few spp. spores. Infections produce diverse clinical manifestations, ranging from insignificant to extremely destructive, even fatal. Approaches to understanding this range of consequences have traditionally categorized patients into a small number of groups (asymptomatic, uncomplicated self-limited, fibro-cavitary, and extra-thoracic disseminated) and then looked for immunologic differences among them. Recently, variants within genes of innate pathways have been found to account, in part, for infections that result in disseminated disease. This discovery raises the very attractive theory that, in patients without severe immunosuppression, much of the disease spectrum can be accounted for by various combinations of such deleterious variants in innate pathways. In this review, we summarize what is known about genetic determinants that are responsible for the severity of coccidioidal infections and how complex innate genetic differences among different people might account for the spectrum of disease observed clinically.

摘要

地方性真菌感染球孢子菌病,是在吸入一个或极少数该菌的孢子后发生的。感染会产生多种临床表现,从无明显症状到极具破坏性甚至致命。传统上,理解这一系列后果的方法是将患者分为少数几组(无症状、无并发症的自限性、纤维空洞型和胸外播散型),然后寻找它们之间的免疫差异。最近发现,固有免疫途径基因中的变异部分解释了导致播散性疾病的感染情况。这一发现提出了一个非常有吸引力的理论,即在没有严重免疫抑制的患者中,疾病谱的很大一部分可以由固有免疫途径中此类有害变异的各种组合来解释。在这篇综述中,我们总结了已知的关于决定球孢子菌感染严重程度的遗传因素,以及不同人之间复杂的固有遗传差异如何解释临床上观察到的疾病谱。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1fa/10219288/2206de1f210b/jof-09-00554-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1fa/10219288/082738cdd2c8/jof-09-00554-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1fa/10219288/b83155324df8/jof-09-00554-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1fa/10219288/2206de1f210b/jof-09-00554-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1fa/10219288/082738cdd2c8/jof-09-00554-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1fa/10219288/b83155324df8/jof-09-00554-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1fa/10219288/2206de1f210b/jof-09-00554-g003.jpg

相似文献

1
Genetic and Other Determinants for the Severity of Coccidioidomycosis: A Clinician's Perspective.球孢子菌病严重程度的遗传及其他决定因素:临床医生视角
J Fungi (Basel). 2023 May 11;9(5):554. doi: 10.3390/jof9050554.
2
A review of innate and adaptive immunity to coccidioidomycosis.球孢子菌病的先天性和适应性免疫综述。
Med Mycol. 2019 Feb 1;57(Supplement_1):S85-S92. doi: 10.1093/mmy/myy146.
3
Pulmonary coccidioidomycosis.肺球孢子菌病。
Semin Respir Crit Care Med. 2011 Dec;32(6):754-63. doi: 10.1055/s-0031-1295723. Epub 2011 Dec 13.
4
Host-Pathogen Interactions in Coccidioidomycosis: Prognostic Clues and Opportunities for Novel Therapies.球虫病中的宿主-病原体相互作用:预后线索和新型治疗方法的机会。
Clin Ther. 2019 Oct;41(10):1939-1954.e1. doi: 10.1016/j.clinthera.2019.08.011. Epub 2019 Oct 22.
5
Disseminated coccidioidomycosis in a patient with juvenile idiopathic arthritis receiving infliximab.接受英夫利昔单抗治疗的幼年特发性关节炎患者并发播散性球孢子菌病。
Pediatr Rheumatol Online J. 2021 May 1;19(1):63. doi: 10.1186/s12969-021-00549-7.
6
Coccidioidomycosis: Epidemiology, Fungal Pathogenesis, and Therapeutic Development.球孢子菌病:流行病学、真菌发病机制及治疗进展
Curr Trop Med Rep. 2019 Sep 15;6(3):132-144. doi: 10.1007/s40475-019-00184-z. Epub 2019 Jun 14.
7
Fatal septic shock due to disseminated coccidioidomycosis: a case series and review of the literature.播散性球孢子菌病导致的致死性感染性休克:病例系列及文献复习。
BMC Infect Dis. 2023 Jun 26;23(1):430. doi: 10.1186/s12879-023-08379-6.
8
Coccidioidomycosis Complement Fixation Titer Trends in the Age of Antifungals.抗真菌药物时代的球孢子菌病补体固定滴度趋势。
J Clin Microbiol. 2018 Nov 27;56(12). doi: 10.1128/JCM.01318-18. Print 2018 Dec.
9
Risk factors and outcomes of culture-proven acute Coccidioides spp. infection in San Diego, California, United States.美国加利福尼亚州圣地亚哥培养确诊的急性 Cocciodioidomycosis 感染的危险因素和结局。
Mycoses. 2020 Jun;63(6):553-557. doi: 10.1111/myc.13074. Epub 2020 Apr 1.
10
Dectin-1 is required for resistance to coccidioidomycosis in mice.Dectin-1 对于小鼠对球虫病的抵抗力是必需的。
mBio. 2013 Feb 5;4(1):e00597-12. doi: 10.1128/mBio.00597-12.

引用本文的文献

1
Musculoskeletal manifestations of lower-extremity coccidioidomycosis: a case series.下肢球孢子菌病的肌肉骨骼表现:病例系列
J Bone Jt Infect. 2024 Jul 25;9(4):197-205. doi: 10.5194/jbji-9-197-2024. eCollection 2024.
2
Single-cell analysis of human airway epithelium identifies cell type-specific responses to and .对人类气道上皮细胞的单细胞分析确定了细胞类型对……的特异性反应。 (注:原文中“and”后面内容缺失)
bioRxiv. 2024 Sep 13:2024.09.09.612147. doi: 10.1101/2024.09.09.612147.
3
Coccidioidomycosis in Immunocompromised at a Non-Endemic Referral Center in Mexico.

本文引用的文献

1
Improving Early Recognition of Coccidioidomycosis in Urgent Care Clinics: Analysis of an Implemented Education Program.提高急诊诊所对球孢子菌病的早期识别:对一项已实施的教育计划的分析
Open Forum Infect Dis. 2023 Jan 31;10(1):ofac654. doi: 10.1093/ofid/ofac654. eCollection 2023 Jan.
2
Editorial: Innate immunity and severe asthma: From microbiome to target therapy.社论:先天性免疫与重症哮喘:从微生物群落到靶向治疗。
Front Immunol. 2022 Dec 29;13:1114275. doi: 10.3389/fimmu.2022.1114275. eCollection 2022.
3
Psychoneuroimmunology of Meditation.
墨西哥一家非流行地区转诊中心免疫功能低下患者的球孢子菌病
J Fungi (Basel). 2024 Jun 18;10(6):429. doi: 10.3390/jof10060429.
4
Challenges to Implementing a Vaccine for Coccidioidomycosis.实施球孢子菌病疫苗面临的挑战。
Open Forum Infect Dis. 2024 Feb 19;11(6):ofae095. doi: 10.1093/ofid/ofae095. eCollection 2024 Jun.
5
Challenges Facing Antimicrobial Stewardship Programs in the Endemic Region for Coccidioidomycosis.球孢子菌病流行地区抗菌药物管理计划面临的挑战
Open Forum Infect Dis. 2024 Jan 24;11(6):ofae041. doi: 10.1093/ofid/ofae041. eCollection 2024 Jun.
6
A microbial risk assessor's guide to Valley Fever (Coccidioides spp.): Case study and review of risk factors.微生物风险评估人员的 Valley Fever(球孢菌属)指南:案例研究和危险因素回顾。
Sci Total Environ. 2024 Mar 20;917:170141. doi: 10.1016/j.scitotenv.2024.170141. Epub 2024 Jan 17.
7
A Clinicopathological Categorization System for Clinical Research in Coccidioidomycosis.球孢子菌病临床研究的临床病理分类系统
Open Forum Infect Dis. 2023 Nov 29;10(12):ofad597. doi: 10.1093/ofid/ofad597. eCollection 2023 Dec.
冥想的心理神经免疫学
Ann Neurosci. 2022 Apr;29(2-3):170-176. doi: 10.1177/09727531221109117. Epub 2022 Jul 11.
4
Editorial: Impact of microbiome on gut mucosal immunity in health and disease.社论:微生物群对健康与疾病状态下肠道黏膜免疫的影响
Front Immunol. 2022 Sep 20;13:1005156. doi: 10.3389/fimmu.2022.1005156. eCollection 2022.
5
Natural history of pulmonary coccidioidomycosis: Further examination of the VA-Armed Forces Database.肺球孢子菌病的自然史:对 VA-武装部队数据库的进一步研究。
Med Mycol. 2022 Oct 28;60(10). doi: 10.1093/mmy/myac054.
6
Immunogenetics associated with severe coccidioidomycosis.与严重球孢子菌病相关的免疫遗传学。
JCI Insight. 2022 Nov 22;7(22):e159491. doi: 10.1172/jci.insight.159491.
7
Coccidioidomycosis in Northern Arizona: an Investigation of the Host, Pathogen, and Environment Using a Disease Triangle Approach.亚利桑那州北部的球孢子菌病:采用疾病三角关系方法研究宿主、病原体和环境。
mSphere. 2022 Oct 26;7(5):e0035222. doi: 10.1128/msphere.00352-22. Epub 2022 Aug 16.
8
Coccidioidomycosis and COVID-19 Infection. An Analysis from a Single Medical Center Within the Coccidioidal Endemic Area.球孢子菌病和 COVID-19 感染。在球孢子菌流行地区的单一医疗中心进行的分析。
Mycopathologia. 2022 Jun;187(2-3):199-204. doi: 10.1007/s11046-022-00629-6. Epub 2022 Apr 15.
9
Sex Differences in Susceptibility to Coccidioidomycosis.球孢子菌病易感性的性别差异
Open Forum Infect Dis. 2022 Feb 16;9(3):ofab543. doi: 10.1093/ofid/ofab543. eCollection 2022 Mar.
10
TNFα Blockade Inhibits Both Initial and Continued Control of Pulmonary .TNFα 阻断剂抑制肺部的初始和持续控制。
Front Cell Infect Microbiol. 2022 Jan 31;11:796114. doi: 10.3389/fcimb.2021.796114. eCollection 2021.